Clinical Trial Update: Long-term Study Of Paroxetine in Women and Men [Phase 3]

View source ↗

Summary

Completed Phase 3 long-term study evaluating paroxetine in men and women with social anxiety disorder (social phobia) sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Phase 3 | Status: COMPLETED